• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓素生成在臭氧诱导的犬气道高反应性中的意义。

Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs.

作者信息

Aizawa H, Chung K F, Leikauf G D, Ueki I, Bethel R A, O'Byrne P M, Hirose T, Nadel J A

出版信息

J Appl Physiol (1985). 1985 Dec;59(6):1918-23. doi: 10.1152/jappl.1985.59.6.1918.

DOI:10.1152/jappl.1985.59.6.1918
PMID:3935642
Abstract

To determine whether thromboxane A2 may be involved in ozone (O3)-induced airway hyperresponsiveness, we studied the effect of a thromboxane synthase inhibitor (OKY-046, 100 micrograms X kg-1 X min-1 iv) in five dogs exposed to O3. Airway responsiveness was assessed by determining the provocative concentration of acetylcholine aerosol that increased total pulmonary resistance by 5 cmH2O X l-1 X s. O3 (3 ppm) increased airway responsiveness as demonstrated by a decrease in acetylcholine provocative concentration from 2.42 (geometric SEM = 1.64) to 0.14 mg/ml (geometric SEM = 1.30). OKY-046 significantly inhibited this effect without altering pre-O3 responsiveness or the O3-induced increase in neutrophils and airway epithelial cells in bronchoalveolar lavage fluid. To further examine the role of thromboxane A2, we studied the effect of a thromboxane A2 mimetic, U-46619, on airway responsiveness in five additional dogs. U-46619 in subthreshold doses (i.e., insufficient to increase base-line pulmonary resistance) caused a fourfold increase in airway responsiveness to acetylcholine. Subthreshold doses of histamine had no effect. These results suggest that thromboxane A2 may be an important mediator of O3-induced airway hyperresponsiveness.

摘要

为了确定血栓素A2是否可能参与臭氧(O3)诱导的气道高反应性,我们研究了血栓素合酶抑制剂(OKY - 046,100微克×千克-1×分钟-1静脉注射)对五只暴露于O3的犬的影响。通过测定使总肺阻力增加5厘米水柱×升-1×秒的乙酰胆碱气雾剂激发浓度来评估气道反应性。O3(3 ppm)增加了气道反应性,表现为乙酰胆碱激发浓度从2.42(几何标准误=1.64)降至0.14毫克/毫升(几何标准误=1.30)。OKY - 046显著抑制了这种作用,而不改变O3暴露前的反应性或O3诱导的支气管肺泡灌洗液中中性粒细胞和气道上皮细胞的增加。为了进一步研究血栓素A2的作用,我们研究了血栓素A2模拟物U - 46619对另外五只犬气道反应性的影响。亚阈值剂量的U - 46619(即不足以增加基线肺阻力)使气道对乙酰胆碱的反应性增加了四倍。亚阈值剂量的组胺则没有作用。这些结果表明,血栓素A2可能是O3诱导的气道高反应性的重要介质。

相似文献

1
Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs.血栓素生成在臭氧诱导的犬气道高反应性中的意义。
J Appl Physiol (1985). 1985 Dec;59(6):1918-23. doi: 10.1152/jappl.1985.59.6.1918.
2
Effect of an inhaled thromboxane mimetic (U46619) on in vivo pulmonary resistance and airway hyperresponsiveness in dogs.吸入性血栓素类似物(U46619)对犬体内肺阻力和气道高反应性的影响。
J Physiol. 1992;453:59-67. doi: 10.1113/jphysiol.1992.sp019218.
3
Effect of thromboxane antagonists on ozone-induced airway responses in dogs.
J Appl Physiol (1985). 1990 Sep;69(3):880-4. doi: 10.1152/jappl.1990.69.3.880.
4
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.
J Pharmacol Exp Ther. 1986 Mar;236(3):580-4.
5
Ozone increases susceptibility to antigen inhalation in allergic dogs.臭氧会增加过敏性犬只对抗原吸入的易感性。
J Appl Physiol (1985). 1990 Jun;68(6):2267-73. doi: 10.1152/jappl.1990.68.6.2267.
6
Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.血栓素合成酶抑制剂(OKY - 046)对变应性犬抗原诱导的气道高反应性的抑制作用
Am Rev Respir Dis. 1986 Aug;134(2):258-61. doi: 10.1164/arrd.1986.134.2.258.
7
Leukotriene B4 induces airway hyperresponsiveness in dogs.
J Appl Physiol (1985). 1985 Dec;59(6):1941-6. doi: 10.1152/jappl.1985.59.6.1941.
8
[Effect of OKY-046 on airway hyperresponsiveness induced by ozone in dogs].
Nihon Yakurigaku Zasshi. 1990 May;95(5):271-7. doi: 10.1254/fpj.95.5_271.
9
Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs.
Eur J Pharmacol. 1990 Aug 2;184(1):87-95. doi: 10.1016/0014-2999(90)90669-w.
10
Cyclooxygenase-2 participates in the late phase of airway hyperresponsiveness after ozone exposure in guinea pigs.环氧化酶-2参与豚鼠臭氧暴露后气道高反应性的晚期阶段。
Eur J Pharmacol. 2000 Sep 8;403(3):267-75. doi: 10.1016/s0014-2999(00)00524-0.

引用本文的文献

1
Acute Respiratory Barrier Disruption by Ozone Exposure in Mice.臭氧暴露致小鼠急性呼吸屏障破坏。
Front Immunol. 2019 Sep 13;10:2169. doi: 10.3389/fimmu.2019.02169. eCollection 2019.
2
Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2.豚鼠注射葡聚糖凝胶珠后早期支气管高反应性:血小板活化因子和血栓素A2的作用
Inflammation. 1999 Oct;23(5):437-48. doi: 10.1023/a:1021913009742.
3
A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.
一种5-脂氧合酶抑制剂FR110302可抑制豚鼠和狗中由臭氧诱导的气道高反应性。
Agents Actions. 1993 Mar;38(3-4):171-7. doi: 10.1007/BF01976208.
4
Leukotriene and thromboxane antagonists.白三烯和血栓素拮抗剂。
Clin Rev Allergy. 1994 Spring;12(1):79-93. doi: 10.1007/BF02815511.
5
Airway epithelial cells modulate cholinergic neurotransmission in dog trachea.气道上皮细胞调节犬气管中的胆碱能神经传递。
Lung. 1994;172(4):241-9. doi: 10.1007/BF00164441.
6
Ipratropium bromide protects against bronchoconstriction during bronchoscopy.
Lung. 1994;172(5):293-8. doi: 10.1007/BF00164311.
7
Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs.血栓素A2通过增强豚鼠支气管反应性对IgG1抗体介导的抗原诱导即刻哮喘反应的作用。
Br J Pharmacol. 1994 Jan;111(1):339-45. doi: 10.1111/j.1476-5381.1994.tb14065.x.
8
Ozone exposure suppresses epithelium-dependent relaxation in feline airway.臭氧暴露会抑制猫气道中上皮细胞依赖的舒张反应。
Lung. 1995;173(1):47-56. doi: 10.1007/BF00167600.
9
The effect of ozone on reactivity of upper and lower airways in guinea-pigs.臭氧对豚鼠上、下呼吸道反应性的影响。
Br J Pharmacol. 1988 Jul;94(3):938-46. doi: 10.1111/j.1476-5381.1988.tb11607.x.
10
A possible role of airway epithelium in modulating hyperresponsiveness.气道上皮在调节高反应性中的可能作用。
Br J Pharmacol. 1988 Jan;93(1):139-45. doi: 10.1111/j.1476-5381.1988.tb11414.x.